BOONTON, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that Ashleigh Palmer, President and Chief Executive Officer will be presenting a corporate overview at the ROTH 23rd Annual OC Growth Stock Conference. Mr. Palmer’s presentation is scheduled to begin at 10:00 a.m. Pacific Time on Tuesday, March 15, 2011.
